Revaluation of Clopidogrel: Let the Data Speak for Themselves

LIU LI; ZENG FANDIAN; ZENG XIAOHUA; XUE QINGMEI; NIE SHAOPING; KANG CAILIAN; WU JIANHONG; KANG QINGYUN; WANG XINGAO; LIU XIAOQING; LI TAO; CHEN JUN; LI QING; XU RONG; YANG XIAOYAN; KANG HUI; JIANG FAGANG; LI ZONGTAO; WANG XUWU; ZHANG LI; LONG YU.
Journal of Huazhong University of Science and Technology (Medical Sciences) ; (6): 299-306, 2010.
Artículo en Zh | WPRIM | ID: wpr-349833

Documentos relacionados

  1. Revaluation of clopidogrel: let the data speak for themselves.
  2. Revaluation of clopidogrel: let the data speak for themselves
  3. [Proton pump inhibitors and clopidogrel: an association to avoid?].
  4. [Resistance to acetylsalicylic acid and clopidogrel: current status].
  5. [Proton pump inhibitors when using clopidogrel: balance between necessity and disadvantages].
  6. [Clopidogrel: background information and use in clinical practice].
  7. [Dual antiplatelet drug resistance in a patient allergic to clopidogrel: a case report].
  8. [Stent thrombosis and clopidogrel response variability: is the genetic test useful in clinical practice?].
  9. Wearing Compression Garment Enhances Central Hemodynamics? A Systematic Review and Meta-Analysis.
  10. Biomedical research in france and brazil: an analysis of significant differences and ethical issues